STOCK TITAN

Aethlon Medical Inc - AEMD STOCK NEWS

Welcome to our dedicated news page for Aethlon Medical (Ticker: AEMD), a resource for investors and traders seeking the latest updates and insights on Aethlon Medical.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Aethlon Medical's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Aethlon Medical's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.55%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.04%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.26%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.21%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.02%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
39.51%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.5%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.62%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.2%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.01%
Tags
conferences
Aethlon Medical Inc

Nasdaq:AEMD

AEMD Rankings

AEMD Stock Data

3.79M
2.57M
1.42%
1.99%
0.72%
Analytical Laboratory Instrument Manufacturing
Manufacturing
Link
US
San Diego

About AEMD

the aethlon medical (nasdaq:aemd) mission is to create innovative devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. our aethlon adapt™ platform provides the technology foundation for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. the aethlon adapt™ product pipeline includes the hemopurifier®, a first-in-class medical device with broad-spectrum capabilities against exosomes that contribute to the progression of cancer and infectious viral pathogens such as hiv and hepatitis c.